Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OneMedNet (ONMD) Common Equity (2022 - 2025)

OneMedNet (ONMD) has disclosed Common Equity for 4 consecutive years, with -$3.9 million as the latest value for Q3 2025.

  • On a quarterly basis, Common Equity rose 72.39% to -$3.9 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$3.9 million, a 72.39% increase, with the full-year FY2024 number at -$16.0 million, down 18.66% from a year prior.
  • Common Equity was -$3.9 million for Q3 2025 at OneMedNet, down from -$3.8 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of -$3.8 million in Q2 2025 to a low of -$47.8 million in Q3 2023.
  • A 4-year average of -$18.0 million and a median of -$15.7 million in 2024 define the central range for Common Equity.
  • Peak YoY movement for Common Equity: crashed 490.49% in 2023, then soared 79.99% in 2025.
  • OneMedNet's Common Equity stood at -$26.4 million in 2022, then surged by 49.0% to -$13.4 million in 2023, then fell by 18.66% to -$16.0 million in 2024, then soared by 75.3% to -$3.9 million in 2025.
  • Per Business Quant, the three most recent readings for ONMD's Common Equity are -$3.9 million (Q3 2025), -$3.8 million (Q2 2025), and -$16.6 million (Q1 2025).